Published in J Appl Physiol (1985) on May 01, 1998
Satellite cells and the muscle stem cell niche. Physiol Rev (2013) 3.40
Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol (2002) 2.76
Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci U S A (2009) 2.29
Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skelet Muscle (2011) 2.10
Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. J Physiol (2002) 2.09
A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy. J Physiol (2007) 2.03
The insulin-like growth factor (IGF)-I E-peptides are required for isoform-specific gene expression and muscle hypertrophy after local IGF-I production. J Appl Physiol (1985) (2010) 1.83
Early activation of mTORC1 signalling in response to mechanical overload is independent of phosphoinositide 3-kinase/Akt signalling. J Physiol (2011) 1.59
Regulation of muscle mass by growth hormone and IGF-I. Br J Pharmacol (2008) 1.44
Sonic hedgehog regulates angiogenesis and myogenesis during post-natal skeletal muscle regeneration. J Cell Mol Med (2008) 1.27
Cellular mechanisms regulating protein synthesis and skeletal muscle hypertrophy in animals. J Appl Physiol (1985) (2008) 1.26
Increased extraocular muscle strength with direct injection of insulin-like growth factor-I. Invest Ophthalmol Vis Sci (2006) 1.23
Excitation-transcription coupling in skeletal muscle: the molecular pathways of exercise. Biol Rev Camb Philos Soc (2010) 1.23
The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men. J Physiol (2003) 1.19
Cellular and molecular events controlling skeletal muscle mass in response to altered use. Pflugers Arch (2008) 1.13
Mechanotransduction and the regulation of mTORC1 signaling in skeletal muscle. Int J Biochem Cell Biol (2011) 1.10
Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise. J Appl Physiol (1985) (2008) 1.06
Cancer cachexia prevention via physical exercise: molecular mechanisms. J Cachexia Sarcopenia Muscle (2012) 1.05
The insulin-like growth factor (IGF)-I E-peptides modulate cell entry of the mature IGF-I protein. Mol Biol Cell (2009) 1.05
Acute supplementation of amino acids increases net protein accretion in IUGR fetal sheep. Am J Physiol Endocrinol Metab (2012) 1.01
Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr Rev (2012) 1.01
Anabolic effects of IGF-1 signaling on the skeleton. Front Endocrinol (Lausanne) (2013) 1.00
Insulin-like growth factor-I E-peptide activity is dependent on the IGF-I receptor. PLoS One (2012) 1.00
Osteosarcopenic obesity: the role of bone, muscle, and fat on health. J Cachexia Sarcopenia Muscle (2014) 0.99
Local insulin-like growth factor I prevents sepsis-induced muscle atrophy. Metabolism (2009) 0.99
Peripheral androgen receptors sustain the acrobatics and fine motor skill of elaborate male courtship. Endocrinology (2013) 0.98
Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A. Hum Mol Genet (2011) 0.96
Role of microRNAs in skeletal muscle hypertrophy. Front Physiol (2014) 0.95
Deletion of muscle GRP94 impairs both muscle and body growth by inhibiting local IGF production. FASEB J (2012) 0.95
Endocrine regulation of fetal skeletal muscle growth: impact on future metabolic health. J Endocrinol (2014) 0.91
The pro-forms of insulin-like growth factor I (IGF-I) are predominant in skeletal muscle and alter IGF-I receptor activation. Endocrinology (2013) 0.91
Notch and Wnt signaling, physiological stimuli and postnatal myogenesis. Int J Biol Sci (2010) 0.90
Overexpression of insulin-like growth factor-1 attenuates skeletal muscle damage and accelerates muscle regeneration and functional recovery after disuse. Exp Physiol (2013) 0.90
Impact of viral-mediated IGF-I gene transfer on skeletal muscle following cast immobilization. Am J Physiol Endocrinol Metab (2010) 0.88
Thermal manipulations in late-term chick embryos have immediate and longer term effects on myoblast proliferation and skeletal muscle hypertrophy. J Appl Physiol (1985) (2008) 0.87
Molecular events and signalling pathways involved in skeletal muscle disuse-induced atrophy and the impact of countermeasures. J Cell Mol Med (2009) 0.87
Insulin-like 6 is induced by muscle injury and functions as a regenerative factor. J Biol Chem (2010) 0.86
Muscle IGF-I Ea, MGF, and myostatin mRNA expressions after compensatory overload in hypophysectomized rats. Pflugers Arch (2006) 0.86
Contraction-induced changes in TNFalpha and Akt-mediated signalling are associated with increased myofibrillar protein in rat skeletal muscle. Eur J Appl Physiol (2010) 0.86
IGF-I activates the mouse type IIb myosin heavy chain gene. Am J Physiol Cell Physiol (2009) 0.84
Functional deficits and insulin-like growth factor-I gene expression following tourniquet-induced injury of skeletal muscle in young and old rats. J Appl Physiol (1985) (2008) 0.83
Systemic administration of IGF-I enhances healing in collagenous extracellular matrices: evaluation of loaded and unloaded ligaments. BMC Physiol (2007) 0.83
Muscle hypertrophy and increased expression of leptin receptors in the musculus triceps brachii of the dominant arm in professional tennis players. Eur J Appl Physiol (2010) 0.83
Paracrine effects of IGF-1 overexpression on the functional decline due to skeletal muscle disuse: molecular and functional evaluation in hindlimb unloaded MLC/mIgf-1 transgenic mice. PLoS One (2013) 0.82
Exercise training and work task induced metabolic and stress-related mRNA and protein responses in myalgic muscles. Biomed Res Int (2012) 0.82
New Modulators for IGF-I Activity within IGF-I Processing Products. Front Endocrinol (Lausanne) (2013) 0.81
Impairment of IGF-I expression and anabolic signaling following ischemia/reperfusion in skeletal muscle of old mice. Exp Gerontol (2010) 0.81
Role of IGF-I signaling in muscle bone interactions. Bone (2015) 0.80
The neuroprotective effects of intramuscular insulin-like growth factor-I treatment in brain ischemic rats. PLoS One (2013) 0.79
Evolutionary patterns of adaptive acrobatics and physical performance predict expression profiles of androgen receptor - but not oestrogen receptor - in the forelimb musculature. Funct Ecol (2015) 0.79
Viral expression of insulin-like growth factor I E-peptides increases skeletal muscle mass but at the expense of strength. Am J Physiol Endocrinol Metab (2014) 0.78
Optimizing IGF-I for skeletal muscle therapeutics. Growth Horm IGF Res (2014) 0.77
A systematic review of the evidence that brain structure is related to muscle structure and their relationship to brain and muscle function in humans over the lifecourse. BMC Geriatr (2014) 0.77
Role of IGF-I in follistatin-induced skeletal muscle hypertrophy. Am J Physiol Endocrinol Metab (2015) 0.76
Possible involvement of IGF-1 signaling on compensatory growth of the infraspinatus muscle induced by the supraspinatus tendon detachment of rat shoulder. Physiol Rep (2014) 0.75
Serum reference value of two potential doping candidates-myostatin and insulin-like growth factor-I in the healthy young male. J Int Soc Sports Nutr (2017) 0.75
Improvement of Eye Alignment in Adult Strabismic Monkeys by Sustained IGF-1 Treatment. Invest Ophthalmol Vis Sci (2016) 0.75
Effects of sequential injections of hepatocyte growth factor and insulin-like growth factor-I on adult rabbit extraocular muscle. J AAPOS (2012) 0.75
The relationships among IGF-1, DNA content, and protein accumulation during skeletal muscle hypertrophy. J Appl Physiol (1985) (1996) 1.68
Time course of myosin heavy chain transitions in neonatal rats: importance of innervation and thyroid state. Am J Physiol (1999) 1.01
Effects of spaceflight and thyroid deficiency on rat hindlimb development. II. Expression of MHC isoforms. J Appl Physiol (1985) (2000) 0.96
A longitudinal analysis of lymphocyte proliferative responses to mitogens and antigens during human pregnancy. Am J Obstet Gynecol (1981) 0.95
Role of denervation in modulating IIb MHC gene expression in response to T(3) plus unloading state. J Appl Physiol (1985) (2000) 0.95
Metastatic cerebral choriocarcinoma during pregnancy. Minn Med (1980) 0.94
A new animal model for modulating myosin isoform expression by altered mechanical activity. J Appl Physiol (1985) (1992) 0.90
Sustained-release aspirin in children. J Pediatr (1968) 0.88
Cytomegalovirus-specific humoral and cellular immune responses in human pregnancy. J Infect Dis (1981) 0.87
Interaction of hyperthyroidism and hindlimb suspension on skeletal myosin heavy chain expression. J Appl Physiol (1985) (1998) 0.87
Single-fiber and whole muscle analyses of MHC isoform plasticity: interaction between T3 and unloading. Am J Physiol (1997) 0.86
Effects of spaceflight and thyroid deficiency on hindlimb development. I. Muscle mass and IGF-I expression. J Appl Physiol (1985) (2000) 0.86
Role of thyroid hormone and insulin in control of cardiac isomyosin expression. J Mol Cell Cardiol (1997) 0.85
Effects of isometric training on skeletal myosin heavy chain expression. J Appl Physiol (1985) (1998) 0.85
Substrate oxidation capacity in rodent skeletal muscle: effects of exposure to zero gravity. J Appl Physiol (1985) (1993) 0.81
Interaction of thyroid hormone and functional overload on skeletal muscle isomyosin expression. J Appl Physiol (1985) (1994) 0.80
Activity-induced regulation of myosin isoform distribution: comparison of two contractile activity programs. J Appl Physiol (1985) (1993) 0.78
Thyroid receptor plasticity in striated muscle types: effects of altered thyroid state. Am J Physiol (1998) 0.78
Food restriction-induced transformations in cardiac functional and biochemical properties in rats. J Appl Physiol (1985) (1993) 0.76
Effects of diabetes on rodent cardiac thyroid hormone receptor and isomyosin expression. Am J Physiol (1997) 0.75
Choriocarcinoma with cerebral metastases coexistent with a first pregnancy. Am J Obstet Gynecol (1978) 0.75